Product Code: ETC6186175 | Publication Date: Sep 2024 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The neurovascular stent market in Australia is centered around devices used to treat cerebrovascular conditions such as carotid artery stenosis, intracranial aneurysms, and other vascular abnormalities in the brain. These stents help to open blocked arteries and prevent restenosis. The market is supported by advancements in stent designs, which offer improved flexibility, durability, and biocompatibility. The rising incidence of stroke and other vascular diseases in Australia, combined with the increasing preference for endovascular procedures, is driving the demand for neurovascular stents.
The neurovascular stent market in Australia is being driven by the increasing incidence of neurovascular diseases that require stenting procedures, particularly in patients with aneurysms and arteriovenous malformations. A key trend is the development of stents that are more flexible and have better trackability, making them easier to deploy in the intricate vascular structures of the brain. The integration of drug-eluting technologies into stents is another trend, as these stents help prevent restenosis and improve long-term outcomes for patients. There is also a growing emphasis on the use of bioabsorbable stents, which could reduce the need for long-term follow-up treatments and improve patient quality of life.
The neurovascular stent market in Australia encounters challenges involving the need for constant innovation to address restenosis risks and the development of bioresorbable materials. Furthermore, reimbursement complexities and high prices limit broader use across public healthcare systems.
Neurovascular stents are increasingly used in the management of ischemic stroke and aneurysms. The Australian market is attractive for stent innovations focusing on flexibility, retrievability, and biocompatibility. There is also a notable demand for stents tailored to Australias diverse population, where age-related vascular issues are becoming more prevalent. Investors can support local manufacturing and regulatory assistance to gain early market access.
Neurovascular stents are classified as Class III high-risk devices and are subject to detailed conformity assessments and clinical evaluation by the TGA. Government initiatives promoting advanced stroke treatments, along with funding for neurointervention programs, are critical drivers influencing the stent market.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Neurovascular Stent Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Neurovascular Stent Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Neurovascular Stent Market - Industry Life Cycle |
3.4 Australia Neurovascular Stent Market - Porter's Five Forces |
3.5 Australia Neurovascular Stent Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Australia Neurovascular Stent Market Revenues & Volume Share, By Material, 2021 & 2031F |
3.7 Australia Neurovascular Stent Market Revenues & Volume Share, By End Users, 2021 & 2031F |
4 Australia Neurovascular Stent Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Australia Neurovascular Stent Market Trends |
6 Australia Neurovascular Stent Market, By Types |
6.1 Australia Neurovascular Stent Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Neurovascular Stent Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Australia Neurovascular Stent Market Revenues & Volume, By Carotid artery stents, 2021- 2031F |
6.1.4 Australia Neurovascular Stent Market Revenues & Volume, By Intracranial stents, 2021- 2031F |
6.2 Australia Neurovascular Stent Market, By Material |
6.2.1 Overview and Analysis |
6.2.2 Australia Neurovascular Stent Market Revenues & Volume, By Metal, 2021- 2031F |
6.2.3 Australia Neurovascular Stent Market Revenues & Volume, By Polymer, 2021- 2031F |
6.3 Australia Neurovascular Stent Market, By End Users |
6.3.1 Overview and Analysis |
6.3.2 Australia Neurovascular Stent Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Australia Neurovascular Stent Market Revenues & Volume, By Ambulatory Surgical Centers, 2021- 2031F |
6.3.4 Australia Neurovascular Stent Market Revenues & Volume, By Others, 2021- 2031F |
7 Australia Neurovascular Stent Market Import-Export Trade Statistics |
7.1 Australia Neurovascular Stent Market Export to Major Countries |
7.2 Australia Neurovascular Stent Market Imports from Major Countries |
8 Australia Neurovascular Stent Market Key Performance Indicators |
9 Australia Neurovascular Stent Market - Opportunity Assessment |
9.1 Australia Neurovascular Stent Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Australia Neurovascular Stent Market Opportunity Assessment, By Material, 2021 & 2031F |
9.3 Australia Neurovascular Stent Market Opportunity Assessment, By End Users, 2021 & 2031F |
10 Australia Neurovascular Stent Market - Competitive Landscape |
10.1 Australia Neurovascular Stent Market Revenue Share, By Companies, 2024 |
10.2 Australia Neurovascular Stent Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |